Applied DNA Sciences Inc. (APDN)
NASDAQ: APDN
· Real-Time Price · USD
3.90
-0.17 (-4.18%)
At close: Aug 15, 2025, 3:59 PM
3.92
0.38%
After-hours: Aug 15, 2025, 06:13 PM EDT
Applied DNA Sciences Income Statement
Financials in USD. Fiscal
year is
October - September.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
Revenue | 3.79M | 3.74M | 3.43M | 3.4M | 5.52M | 9M | 13.37M | 16.15M | 17.53M | 19.27M | 18.17M | 17.65M | 15.05M | 11.58M | 9.03M | 6.3M | 5.03M | 2.91M |
Cost of Revenue | 2.25M | 2.45M | 2.6M | 2.73M | 3.83M | 5.61M | 7.83M | 10.28M | 11.88M | 12.94M | 13.12M | 12.92M | 10.22M | 6.91M | 4.1M | 1.3M | 908.46K | 731.43K |
Gross Profit | 1.55M | 1.28M | 830.55K | 664.65K | 1.69M | 3.39M | 5.53M | 5.87M | 5.64M | 6.32M | 5.05M | 4.73M | 4.84M | 4.66M | 4.93M | 5M | 4.12M | 2.18M |
Operating Income | -13.04M | -13.2M | -14.02M | -14.92M | -14.44M | -13.52M | -8.32M | -8.51M | -8.49M | -7.78M | -13.83M | -13.92M | -14.45M | -14.77M | -13.11M | -12.71M | -12.53M | -12.9M |
Interest Income | 259.4K | 214.42K | 176.3K | 126.19K | 116.68K | 104.97K | 75.33K | 35.49K | 8.71K | 10.61K | 7.2K | 5.81K | 9.38K | 17.69K | 17.41K | 17.41K | 13.84K | n/a |
Pretax Income | -7.47M | -8.63M | -7.09M | -7.39M | -12.35M | -7.31M | -10.02M | -7.07M | -5.08M | -7.39M | -8.27M | -12.11M | -14.44M | -14.19M | -14.28M | -13.9M | -13.74M | -15.17M |
Net Income | -31.28M | -8.53M | -7.07M | -7.37M | -12.35M | -7.29M | -9.95M | -7.13M | -5.15M | -6.87M | -7.75M | -11.48M | -13.81M | -14.2M | -14.29M | -13.9M | -13.74M | -15.17M |
Selling & General & Admin | 10.98M | 11M | 11.45M | 12.07M | 12.69M | 13.21M | 12.75M | 13.31M | 13.04M | 12.93M | 14.96M | 13.4M | 13.63M | 13.77M | 12.61M | 13.19M | 12.54M | 11.27M |
Research & Development | 3.61M | 3.49M | 3.41M | 3.51M | 3.44M | 3.7M | 3.74M | 3.71M | 3.74M | 3.82M | 3.93M | 4.13M | 4.29M | 4.1M | 3.77M | 3.89M | 3.68M | 3.51M |
Other Expenses | n/a | 4.58K | -8.96K | -14.71K | -18.18K | -22.1K | 284.00 | 6.04K | 9.51K | 8.85K | n/a | -52.04K | -134.84K | -189.72K | -243.57K | -235.08K | -224.97K | -409.7K |
Operating Expenses | 14.59M | 14.48M | 14.86M | 15.59M | 16.13M | 16.91M | 16.49M | 17.02M | 16.77M | 16.74M | 18.89M | 17.83M | 18.47M | 18.62M | 17.22M | 17.71M | 16.66M | 15.08M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 872.08K | 872.08K | 872.08K | 877.52K | 34.46K | 63.08K | 92.18K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.19M | -1.19M | -1.19M | -1.19M | n/a | n/a | n/a |
Cost & Expenses | 16.83M | 16.94M | 17.46M | 18.32M | 19.95M | 22.52M | 24.32M | 27.3M | 28.66M | 29.69M | 32M | 30.75M | 28.68M | 25.53M | 21.32M | 19.01M | 17.56M | 15.81M |
Income Tax Expense | 23.89M | n/a | n/a | -23.39K | -37.82K | -37.82K | -38.69K | 93.21K | -1.65M | -2.28M | -2.28M | -693.79K | 1.06M | 1.7M | 1.7M | -2.21K | -2.88K | -1.66K |
Shares Outstanding (Basic) | 1.77M | 31.52M | 17.74M | 4.01M | 871.32K | 13.67M | 678.44K | 645.43K | 645.43K | 640.56K | 565.82K | 485.03K | 404.23K | 374.31K | 374.73K | 361.75K | 361.75K | 272.9K |
Shares Outstanding (Diluted) | 1.77M | 31.52M | 17.74M | 4.01M | 871.32K | 13.67M | 678.44K | 645.43K | 645.43K | 645.43K | 565.82K | 485.03K | 404.23K | 374.31K | 374.73K | 361.75K | 361.75K | 272.9K |
EPS (Basic) | -15.63 | -5.41 | -6.65 | -11.75 | -17.02 | -10.98 | -15.18 | -11.26 | -8.78 | -12.48 | -19.09 | -29.76 | -36.97 | -38.37 | -43.38 | -47.38 | -52.22 | -63.74 |
EPS (Diluted) | -15.63 | -5.41 | -6.58 | -11.68 | -16.95 | -10.91 | -15.13 | -11.21 | -8.73 | -12.43 | -19.09 | -29.76 | -36.97 | -38.37 | -43.38 | -47.38 | -52.22 | -63.74 |
EBITDA | -12.77M | -12.74M | -13.33M | -13.98M | -13.27M | -12.2M | -9.59M | -9.67M | -9.7M | -9.17M | -12.68M | -12.19M | -12.84M | -13.13M | -11.62M | -12.2M | -12.13M | -12.63M |
EBIT | -9.58M | -13.2M | -14.02M | -14.92M | -14.44M | -13.52M | -10.95M | -11.15M | -11.15M | -10.6M | -14.09M | -13.35M | -13.94M | -14.1M | -12.37M | -12.83M | -12.57M | -12.94M |
Depreciation & Amortization | 269.73K | 456.05K | 696.42K | 949.12K | 1.16M | 1.32M | 1.36M | 1.36M | 1.33M | 1.31M | 1.29M | 1.26M | 1.19M | 1.07M | 844.44K | 626.83K | 440.92K | 308.07K |